Sigrid Therapeutics
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Stockholm, Swedenwww.sigridthx.com ↗
Total raised
€12M
€12,028,749
Funding rounds
3
Investors
9
distinct backers
Active since
2021-11
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
Medium confidenceRaise-next likelihood23
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-07 | Other | €4.3M | undisclosed investors | View deal → |
| 2023-01-17 | Other | €536k | Mattias Ankarberg,Private Investors | View deal → |
| 2021-11-10 | Other | €7.2M | Barbara Bergström,Crosslight Partners,Hans Bergström,Irrus Investments,Joyance Partners,Matsson family | View deal → |
Investors
9Related news
- Swedish deep tech startup raises further €536.3K in oversubscribed rights issuearcticstartup.com · 2023-01
- Diabetesbolag plockar in 72 miljoner – hennes pulver ska lösa sjukdomardi.se · 2021-11
- finsmes.com